These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
591 related items for PubMed ID: 9103386
1. Correlation between human papillomavirus positivity and p53 gene overexpression in adenocarcinoma of the uterine cervix. Uchiyama M, Iwasaka T, Matsuo N, Hachisuga T, Mori M, Sugimori H. Gynecol Oncol; 1997 Apr; 65(1):23-9. PubMed ID: 9103386 [Abstract] [Full Text] [Related]
2. Adenocarcinoma of the uterine cervix in Ireland and Sweden: human papillomavirus infection and biologic alterations. Skyldberg BM, Murray E, Lambkin H, Kelehan P, Auer GU. Mod Pathol; 1999 Jul; 12(7):675-82. PubMed ID: 10430271 [Abstract] [Full Text] [Related]
3. Physical status and expression of HPV genes in cervical cancers. Park JS, Hwang ES, Park SN, Ahn HK, Um SJ, Kim CJ, Kim SJ, Namkoong SE. Gynecol Oncol; 1997 Apr; 65(1):121-9. PubMed ID: 9103401 [Abstract] [Full Text] [Related]
4. Human papillomavirus detection and p53 expression in clear-cell adenocarcinoma of the vagina and cervix. Waggoner SE, Anderson SM, Van Eyck S, Fuller J, Luce MC, Herbst AL. Obstet Gynecol; 1994 Sep; 84(3):404-8. PubMed ID: 8058239 [Abstract] [Full Text] [Related]
5. Alterations of the p53 gene in human primary cervical carcinoma with and without human papillomavirus infection. Fujita M, Inoue M, Tanizawa O, Iwamoto S, Enomoto T. Cancer Res; 1992 Oct 01; 52(19):5323-8. PubMed ID: 1327506 [Abstract] [Full Text] [Related]
6. Analysis of human papillomavirus infection and molecular alterations in adenocarcinoma of the cervix. Ferguson AW, Svoboda-Newman SM, Frank TS. Mod Pathol; 1998 Jan 01; 11(1):11-8. PubMed ID: 9556417 [Abstract] [Full Text] [Related]
7. Human papillomavirus DNA in adenocarcinoma and adenosquamous carcinoma of the uterine cervix detected by polymerase chain reaction (PCR). Yamakawa Y, Forslund O, Teshima H, Hasumi K, Kitagawa T, Hansson BG. Gynecol Oncol; 1994 May 01; 53(2):190-5. PubMed ID: 8188078 [Abstract] [Full Text] [Related]
8. Human papillomavirus infection and p53 alteration in oral squamous cell carcinoma. Cao J, Zhang ZY, Patima, Zhang YX, Chen WT. Chin J Dent Res; 2000 Nov 01; 3(3):44-9. PubMed ID: 11314535 [Abstract] [Full Text] [Related]
9. Human papillomavirus DNA in uterine cervix squamous cell carcinoma and adenocarcinoma detected by polymerase chain reaction. Iwasawa A, Nieminen P, Lehtinen M, Paavonen J. Cancer; 1996 Jun 01; 77(11):2275-9. PubMed ID: 8635095 [Abstract] [Full Text] [Related]
10. Cervical squamous dysplasias and carcinomas with immunodetectable p53 frequently contain HPV. Mittal KR, Lin O, Chan W, Goswami S, Demopoulos RI. Gynecol Oncol; 1995 Sep 01; 58(3):289-94. PubMed ID: 7672694 [Abstract] [Full Text] [Related]
11. Genetic alterations of the TP53 gene, p53 protein expression and HPV infection in primary cervical carcinomas. Helland A, Holm R, Kristensen G, Kaern J, Karlsen F, Trope C, Nesland JM, Børresen AL. J Pathol; 1993 Oct 01; 171(2):105-14. PubMed ID: 8283348 [Abstract] [Full Text] [Related]
12. Squamous cell carcinoma of the endometrium with human papillomavirus type 31 and without tumor suppressor gene p53 mutation. Kataoka A, Nishida T, Sugiyama T, Hori K, Honda S, Yakushiji M. Gynecol Oncol; 1997 Apr 01; 65(1):180-4. PubMed ID: 9103411 [Abstract] [Full Text] [Related]
13. Correlation between HPV positivity and state of the p53 gene in cervical carcinoma cell lines. Iwasaka T, Oh-uchida M, Matsuo N, Yokoyama M, Fukuda K, Hara K, Fukuyama K, Hori K, Sugimori H. Gynecol Oncol; 1993 Jan 01; 48(1):104-9. PubMed ID: 8380785 [Abstract] [Full Text] [Related]
14. Expression of p16, Rb, and p53 proteins in squamous cell carcinomas of the anorectal region harboring human papillomavirus DNA. Lu DW, El-Mofty SK, Wang HL. Mod Pathol; 2003 Jul 01; 16(7):692-9. PubMed ID: 12861066 [Abstract] [Full Text] [Related]
15. The presence of high-risk HPV combined with specific p53 and p16INK4a expression patterns points to high-risk HPV as the main causative agent for adenocarcinoma in situ and adenocarcinoma of the cervix. Zielinski GD, Snijders PJ, Rozendaal L, Daalmeijer NF, Risse EK, Voorhorst FJ, Jiwa NM, van der Linden HC, de Schipper FA, Runsink AP, Meijer CJ. J Pathol; 2003 Dec 01; 201(4):535-43. PubMed ID: 14648656 [Abstract] [Full Text] [Related]
16. "Low-risk" and "high-risk" HPV-infection and K-ras gene point mutations in human cervical cancer: a study of 31 cases. Stenzel A, Semczuk A, Rózyńskal K, Jakowicki J, Wojcierowski J. Pathol Res Pract; 2001 Dec 01; 197(9):597-603. PubMed ID: 11569923 [Abstract] [Full Text] [Related]
17. Analysis and clinical implications of p53 gene mutations and human papillomavirus type 16 and 18 infection in primary adenocarcinoma of the uterine cervix. Tenti P, Pavanello S, Padovan L, Spinillo A, Vesentini N, Zappatore R, Migliora P, Zara C, Ranzani GN, Carnevali L. Am J Pathol; 1998 Apr 01; 152(4):1057-63. PubMed ID: 9546366 [Abstract] [Full Text] [Related]
18. p53 overexpression and human papillomavirus infection in transitional cell carcinoma of the urinary bladder: correlation with histological parameters. Tenti P, Zappatore R, Romagnoli S, Civardi E, Giunta P, Scelsi R, Stella G, Carnevali L. J Pathol; 1996 Jan 01; 178(1):65-70. PubMed ID: 8778319 [Abstract] [Full Text] [Related]
19. Mutations in the p53 gene and human papillomavirus infection as significant prognostic factors in squamous cell carcinomas of the oral cavity. Chiba I, Shindoh M, Yasuda M, Yamazaki Y, Amemiya A, Sato Y, Fujinaga K, Notani K, Fukuda H. Oncogene; 1996 Apr 18; 12(8):1663-8. PubMed ID: 8622886 [Abstract] [Full Text] [Related]
20. Expression of p53 protein related to the presence of human papillomavirus (HPV) DNA in genital carcinomas and precancer lesions. Tervahauta AI, Syrjänen SM, Väyrynen M, Saastamoinen J, Syrjänen KJ. Anticancer Res; 1993 Apr 18; 13(4):1107-11. PubMed ID: 8394670 [Abstract] [Full Text] [Related] Page: [Next] [New Search]